electroCore, Inc. $ECOR

What the company doesAI summary of filing

electroCore is a bioelectronic technology company that develops and sells prescription medical devices and consumer wellness products. The company's primary revenue-generating products are gammaCore, an FDA-cleared prescription device for treating primary headache conditions including migraine and cluster headache, and Quell Fibromyalgia, an FDA-authorized prescription wearable device for reducing fibromyalgia symptoms. The company also sells Truvaga and TAC-STIM as over-the-counter general wellness products. electroCore generates revenue primarily from U.S. government customers (the Department of Veterans Affairs and Department of Defense accounted for 71.2% of 2025 revenue) and the United Kingdom National Health Service, with additional sales through specialty pharmacies, direct-to-consumer channels, and distribution partners in select overseas markets. [10-K 2026-03-19]

Segments: gammaCore (prescription vagus nerve stimulation for headache), Quell Fibromyalgia (prescription wearable neuromodulation device), Truvaga (consumer wellness device), TAC-STIM (non-prescription human performance device)